Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2004
05/20/2004US20040096823 Virion-based fusion assay
05/20/2004US20040096822 HCV antigen/antibody combination assay
05/20/2004US20040096466 Plasmodium falciparum antigens inducing protective antibodies
05/20/2004US20040096462 Noval vaccine formulation consisting of dna vaccine and inactivated virus
05/20/2004US20040096460 Attenuated forms of the virus produced by mutating specific regions of the viral genome. The virus and mutated forms of the virus may be used to induce the production of antibodies to FIV-141, and in vaccines designed to protect cats from FIV,
05/20/2004US20040096459 Polypeptides to be administered especially to humans and in particular for therapeutic use. The polypeptide to elicit an immune response upon administration to the human subject.
05/20/2004US20040096458 Fusion protein construct and method for inducing HIV-specific serum IgG and secretory IgA antibodies in-vivo
05/20/2004US20040096456 Isolated and purified peptides and variants thereof, as well as DNA encoding those peptides, useful to prevent or treat antibody inhibitors of factor VIII
05/20/2004US20040096454 Novel Cryptosporidium parvum protein disulfide isomerase polypeptide, and nucleic acids that encode this polypeptide. The invention also provides methods, reagents, and kits that are useful for diagnosing infection by Cryptosporidium
05/20/2004US20040096452 Multivalent vaccines for the treatment of B-cell malignancies (e.g., lymphomas and leukemias) . The present invention also provides methods for the production of custom vaccines, including multivalent vaccines for the treatment of immune
05/20/2004US20040096450 Determining the prophylactic suitability and quality control of compositions, such as intravenous immunoglobulin mixtures and Fac proteins for use in such methods, of preparing compositions for treating such disorders.
05/20/2004US20040096448 Nucleic acid molecules encoding a protein interacting with ser/thr kinase akt
05/20/2004US20040096444 Identification of the endothelial receptor for the angiostatin kringle-5
05/20/2004US20040096443 Treatment of neurodegenerative diseases and conditions using par1 antagonists
05/20/2004US20040096442 Modified anti-egfr antibodies with reduced immunogenicity
05/20/2004US20040096429 Method for producing cytotoxic T-cells
05/20/2004US20040096426 Compositions and methods for identifying antigens which elicit an immune response
05/20/2004US20040096397 Sulfonated diarylrhodamine dyes
05/19/2004EP1420031A2 Bone morphogenetic protein (BMP)-18 compositions
05/19/2004EP1419782A1 Use of consensus interferon for reducing the side-effects of interferon treatment in viral hepatitis
05/19/2004EP1419392A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs
05/19/2004EP1419390A2 High-throughput assays for the proteolytic activities of clostridial neurotoxins
05/19/2004EP1419277A2 Isolation of membrane bound ligand-specific complexes
05/19/2004EP1419276A2 Diagnosis and treatment of diseases associated with altered expression of hipk1
05/19/2004EP1419265A2 Gene associated with bone disorders
05/19/2004EP1419263A2 Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
05/19/2004EP1419260A2 Recombinant vector derived from adeno-associated virus for gene therapy
05/19/2004EP1419258A2 Plasmids from an extremely thermophilic microorganism and derived expression vectors
05/19/2004EP1419257A1 Methylation resistant vectors
05/19/2004EP1419256A2 Conjugates for the modulation of immune responses
05/19/2004EP1419254A2 Genetic products of ashbya gossypii, associated with transmembrane transport
05/19/2004EP1419252A2 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors
05/19/2004EP1419251A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/19/2004EP1419250A2 Lp mammalian proteins; related reagents
05/19/2004EP1419249A2 TIMM8b-RELATED PROTEIN
05/19/2004EP1419235A2 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit
05/19/2004EP1419178A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
05/19/2004EP1419177A2 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine
05/19/2004EP1419176A2 Glycoconjugates of sialic acid derivates, methods for their production and use thereof
05/19/2004EP1419175A2 Replikin peptides and uses thereof
05/19/2004EP1419172A2 Bi-directional synthesis of oligoguanidine transport agents
05/19/2004EP1419171A1 Methods for purification of an activated peg solution and for the synthesis of a modified hemoglobin solution
05/19/2004EP1418943A1 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
05/19/2004EP1418941A2 Vaccination against the feline immunodeficiency virus
05/19/2004EP1418940A2 Dna expression vectors and methods of use
05/19/2004EP1418931A1 New drug
05/19/2004EP1418930A2 Mucosal repair by tff2 peptides
05/19/2004EP1418805A2 Animal model with disrupted $i(fgf14) gene
05/19/2004EP1353943A4 NOVEL GENE ENCODING AN F-BOX PROTEIN WHICH REGULATES LEAF LONGEVITY IN i ARABIDOPSIS THALIANA /i AND MUTANT GENE THEREOF
05/19/2004EP1304116A4 New class of bioactive glycoprotein
05/19/2004EP1234024B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
05/19/2004EP1151143A4 Selection of proteins using rna-protein fusions
05/19/2004EP1037927B1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
05/19/2004EP1017810B1 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
05/19/2004EP1007551B1 Vaccine against hpv
05/19/2004EP0993616B1 Reagent for detecting and monitoring viral infections
05/19/2004EP0970372B1 Assay for disease related conformation of a protein
05/19/2004EP0960123A4 Sprouty protein and coding sequence
05/19/2004EP0954528B1 A method for chromatographic removal of prions
05/19/2004EP0870026B1 Ob protein derivatives having prolonged half-life
05/19/2004EP0834560B1 Fine magnetic particles containing useful proteins bound thereto, process for producing the same, and use thereof
05/19/2004EP0832253B1 Nucleic acid respiratory syncytial virus vaccines
05/19/2004EP0832113B1 Peptides for hiv-1 detection
05/19/2004EP0787190B1 Hepatitis e virus antigens and uses therefor
05/19/2004EP0711173B1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof
05/19/2004EP0682703B1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS
05/19/2004EP0672754B1 Plant virus vector, plasmid, method of expressing foreign gene, and method of acquiring foreign gene product
05/19/2004EP0637237B1 Calcium receptor-active molecules
05/19/2004DE10250368A1 Mittel und Verfahren zur Diagnose einer Treponemainfektion Means and methods for diagnosis of a Treponema infection
05/19/2004DE10250297A1 Kristalle von Insulinanaloga und Verfahren zu ihrer Herstellung Crystals of insulin analogs and methods for their preparation
05/19/2004CN1498272A Modulating developmental transitions in plants
05/19/2004CN1498271A Potassium channel interactors protein and uses therefor
05/19/2004CN1498270A Gene disrupted yeast
05/19/2004CN1498226A Thrombin derivatives and its process for production, anhydrothrombin derivatives and its production method, platelet agglutination-inducing compositions, method of inducing platelet agglutination,...
05/19/2004CN1498225A Template-fixed peptidomimetics with antimicrobial activity
05/19/2004CN1497049A Androgen receptor compound-associated protein
05/19/2004CN1496993A Albumin purifaction
05/19/2004CN1496992A Recombination soluble tissue factor and preparation method and opplication thereof
05/19/2004CN1150404C Inhibition of Tau-Tau association
05/19/2004CN1150333C Method for producing nucleic acid substances
05/19/2004CN1150330C Induction of male sterility in plants by expression of high levels of avidin
05/19/2004CN1150327C Producing erythrocyte irritable factor/granulocyte colony irritable factor fusion protein by genetic engineering method
05/19/2004CN1150326C Mutant of human tissue type plasminogen activator
05/19/2004CN1150320C Plant transformation methods
05/19/2004CN1150319C Identification of human cell lines for prodn. of human proteins by endogenous gene activation
05/19/2004CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies
05/19/2004CN1150313C Method for the production of polypeptides
05/19/2004CN1150208C Thymosin aplpha-1 derivatives
05/19/2004CN1150207C Gclq receptor, HIV-1 ph120 region binding thereto, and related peptides and targeting antibodies
05/19/2004CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein
05/19/2004CN1150028C Tri-, tetra-, penta- and polypeptides and their therapeuitc use as antidepressant agent
05/19/2004CN1150004C Low temperature albumin fractionation using sodium caprylates as partitioning agent
05/18/2004US6737561 Gene encoding short integuments and uses thereof
05/18/2004US6737560 For producing male sterile plants
05/18/2004US6737559 Fish for use as animal model in evaluating tumor propagation
05/18/2004US6737523 For treatment of various forms of cancer
05/18/2004US6737522 Chicken interleukin-15 and uses thereof
05/18/2004US6737521 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
05/18/2004US6737519 Human genes relating to respiratory diseases and obesity
05/18/2004US6737515 Follicle stimulating hormone-glycosylation analogs